181
Views
10
CrossRef citations to date
0
Altmetric
Review

Clinical Utility Of Elagolix As An Oral Treatment For Women With Uterine Fibroids: A Short Report On The Emerging Efficacy Data

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 535-546 | Published online: 22 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mohamed Ali, Mohamed Raslan, Michał Ciebiera, Kornelia Zaręba & Ayman Al-Hendy. (2022) Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids. Expert Opinion on Drug Safety 21:4, pages 477-486.
Read now
Mohamed Ali, Hsin-Yuan Chen, Yi-Fen Chiang, Osama A Badary, Shih-Min Hsia & Ayman Al-Hendy. (2022) An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Expert Opinion on Pharmacotherapy 23:4, pages 421-429.
Read now
Mohamed Ali, Sara A.R.Ayman Al Hendy. (2021) Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Expert Review of Clinical Pharmacology 14:4, pages 427-437.
Read now

Articles from other publishers (7)

Juliawati Muhammad, Yusnita Yusof, Imran Ahmad & Mohd Noor Norhayati. (2022) Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis. BMC Women's Health 22:1.
Crossref
Daniel Ernesto Carvallo Ruiz, Elizabeth Natalia Martínez-Núñez & José Núñez-Troconis. (2022) Gynecological uses of GnRH antagonists: review article. Obstetrics & Gynecology International Journal 13:4, pages 226-238.
Crossref
Ahmed Nader, Nael M. Mostafa, Elaine Kim & Mohamad Shebley. (2022) Effects of elagolix on the pharmacokinetics of omeprazole and its metabolites in healthy premenopausal women. Clinical and Translational Science 15:5, pages 1269-1280.
Crossref
Min Wu & Yi Zhang. (2021) MiR-182 inhibits proliferation, migration, invasion and inflammation of endometrial stromal cells through deactivation of NF-κB signaling pathway in endometriosis. Molecular and Cellular Biochemistry 476:3, pages 1575-1588.
Crossref
Sneh M Toprani & Varsha Kelkar Mane. (2021) Role of DNA damage and repair mechanisms in uterine fibroid/leiomyomas: a review. Biology of Reproduction 104:1, pages 58-70.
Crossref
Akshanth R. Polepally, Juki W. Ng, Ahmed Hamed Salem, Matthew B. Dufek, Apurvasena Parikh, David C. Carter, Kent Kamradt, Nael M. Mostafa & Mohamad Shebley. (2020) Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist. The Journal of Clinical Pharmacology 60:12, pages 1606-1616.
Crossref
Esra Cetin, Ayman Al-Hendy & Michał Ciebiera. (2020) Non-hormonal mediators of uterine fibroid growth. Current Opinion in Obstetrics & Gynecology 32:5, pages 361-370.
Crossref